1. Wilkinson, Emma J, Woodworth, Alexandra M, Parker, Madeline, Dickinson, Joanne L, Holloway, Adele F. 2020. Epigenetic regulation of the ITGB4 gene in prostate cancer. In Experimental cell research, 392, 112055. doi:10.1016/j.yexcr.2020.112055. https://pubmed.ncbi.nlm.nih.gov/32376286/
2. Sung, Jin Sol, Kang, Chan Woo, Kang, Suki, Kim, Baek Gil, Cho, Nam Hoon. 2019. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts. In Oncogene, 39, 664-676. doi:10.1038/s41388-019-1014-0. https://pubmed.ncbi.nlm.nih.gov/31534187/
3. Zhang, Jingjing, Li, Lingjie, Luo, Weiwei, Ma, Shenglin, Zhao, Yanyan. 2024. ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 26, 2979-2992. doi:10.1007/s12094-024-03527-z. https://pubmed.ncbi.nlm.nih.gov/38776034/
4. Ma, Ding, Liu, Shuwen, Liu, Kua, Jiang, Chunping, Wu, Junhua. 2024. MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway. In Cancer biology & therapy, 25, 2314324. doi:10.1080/15384047.2024.2314324. https://pubmed.ncbi.nlm.nih.gov/38375821/
5. Chen, Fuying, Wei, Ruoqu, Deng, Dan, Yao, Zhirong, Li, Ming. 2022. Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China. In Journal of the European Academy of Dermatology and Venereology : JEADV, 37, 411-419. doi:10.1111/jdv.18692. https://pubmed.ncbi.nlm.nih.gov/36287101/
智鼠故事 
